Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Susceptibility for Cervical Lesions: A Meta-Analysis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Long, Shuyu ^a   Yang, Xingliang ^b   Liu, Xiaojiao ^a   Yang, Pei ^a  

^a SICHUAN UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA;

ARTICLE; ASIA; CANCER INVASION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ANALYSIS; ENZYME POLYMORPHISM; ETHNICITY; EUROPE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC ORIGIN; HUMAN; META ANALYSIS (TOPIC); SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; WESTERN HEMISPHERE;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84871352827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052381     Document Type: Article

References (49)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Bosch F, Lorincz A, Munoz N, Meijer C, Shah K, (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265.
3. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
4. Elfgren K, Kalantari M, Moberger B, Hagmar B, Dillner J, (2000) A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol 183: 561-567.
5. Insinga RP, Dasbach EJ, Elbasha EH, (2009) Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis 9: 119-119.
6. Castellsagué X, Muñoz N, (2003) Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. JNCI Monographs 2003: 20-28.
7. Castellsague X, Bosch FX, Munoz N, (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89: 191-199.
8. García-Closas R, Castellsagué X, Bosch X, González CA, (2005) The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 117: 629-637.
9. Van Niekerk W, (1966) Cervical cytological abnormalities caused by folic acid deficiency. Acta Cytol 10: 67-73.
10. Whitehead N, Reyner F, Lindenbaum J, (1973) Megaloblastic changes in the cervical epithelium: association with oral contraceptive therapy and reversal with folic acid. JAMA 226: 1421-1424.
11. VanEenwyk J, Davis FG, Colman N, (1992) Folate, vitamin C, and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1: 119-124.
12. Butterworth Jr C, Hatch KD, Macaluso M, Cole P, Sauberlich HE, et al. (1992) Folate deficiency and cervical dysplasia. JAMA 267: 528-533.
13. Potischman N, Brinton LA, Laiming VA, Reeves WC, Brenes MM, et al. (1991) A case-control study of serum folate levels and invasive cervical cancer. Cancer Res 51: 4785-4789.
14. Sedjo RL, Inserra P, Abrahamsen M, Harris RB, Roe DJ, et al. (2002) Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 11: 353-359.
15. Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, et al. (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64: 8788-8793.
16. Pillai M, Chacko P, Kesari L, Jayaprakash P, Jayaram H, et al. (2003) Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer. J Clin Pathol 56: 569-574.
17. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, et al. (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94: 3290-3295.
18. Yamada K, Chen Z, Rozen R, Matthews RG, (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Nati Acad Sci USA 98: 14853-14858.
19. van der Put NMJ, Gabreëls F, Stevens E, Smeitink JAM, Trijbels FJM, et al. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62: 1044-1051.
20. Prasad V, Wilkhoo H, (2011) Association of the Functional Polymorphism C677T in the Methylenetetrahydrofolate Reductase Gene with Colorectal, Thyroid, Breast, Ovarian, and Cervical Cancers. Onkologie 34: 422-426.
21. Mostowska A, Myka M, Lianeri M, Roszak A, Jagodzinski PP, (2011) Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clin Biochem 44: 596-600.
22. Kohaar I, Kumar J, Thakur N, Hussain S, Niyaz MK, et al. (2010) Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population. Biomarkers 15: 61-68.
23. Kang S, Kim JW, Kang GH, Park NH, Song YS, et al. (2005) Polymorphism in folate-and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 96: 173-180.
24. Lambropoulos A, Agorastos T, Foka Z, Chrisafi S, Constantinidis T, et al. (2003) Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett 191: 187-191.
25. Yang F, Zhou Y, Jiang Y, Fan Y, Li J, (2010) Study on the correlation between polymorphism of MTHFR gene and the pathogenesis of cervical cancer. J China Maternal Child Health 23: 4122-4124.
26. Tong S, Kim MK, Lee JK, Lee JM, Choi SW, et al. (2011) Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and vitamin B12. Cancer Causes Control 22: 63-72.
27. Nandan NK, Wajid S, Biswas S, Juneja SS, Rizvi M, et al. (2008) Allelic variations in 5, 10-methylenetetrahydrofolate reductase gene and susceptibility to cervical cancer in Indian women. Drug Metabolism Lett 2: 18-22.
28. Sull JW, Jee SH, Yi S, Lee JE, Park JS, et al. (2004) The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women. Gynecol Oncol 95: 557-563.
29. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Bertram CC, et al. (2001) Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 10: 1275-1280.
30. Piyathilake C, Macaluso M, Johanning G, Whiteside M, Heimburger D, et al. (2000) Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 20: 1751-1757.
31. Ma X, Wang J, Zhou Q, Ding L, Cheng Y, et al. (2006) Relationship between Methylenetetrahydrofolate reductase polymorphism and cervical cancer susceptibility. China Public Health 22: 1247-1248.
32. Shekari M, Sobti RC, Kordi Tamandani DM, Suri V, (2008) Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 278: 517-524.
33. Piyathilake CJ, Azrad M, Macaluso M, Johanning GL, Cornwell PE, et al. (2007) Protective association of MTHFR polymorphism on cervical intraepithelial neoplasia is modified by riboflavin status. Nutrition 23: 229-235.
34. Zoodsma M, Nolte IM, Schipper M, Oosterom E, van der Steege G, et al. (2005) Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease. Hum Genet 116: 247-254.
35. Agodi A, Barchitta M, Cipresso R, Marzagalli R, La Rosa N, et al. (2010) Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. Int J Gynecol Cancer 20: 141-146.
36. Collin SM, Metcalfe C, Zuccolo L, Lewis SJ, Chen L, et al. (2009) Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 18: 2528-2539.
37. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 6(6): e1000097 doi:10.1371/journal.pmed1000097.
38. Higgins J, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
39. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clini Trials 7: 177-188.
40. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
41. Egger M, Smith GD, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
42. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, et al. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93: 7-9.
43. Ashfield-Watt PAL, Pullin CH, Whiting JM, Clark ZE, Moat SJ, et al. (2002) Methylenetetrahydrofolate reductase 677C>T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutrition 76: 180-186.
44. Hubner RA, Houlston RS, (2007) MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. Int J Cancer 120: 1027-1035.
45. Huang Y, Han S, Li Y, Mao Y, Xie Y, (2007) Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet 52: 73-85.
46. Larsson SC, Giovannucci E, Wolk A, (2006) Folate Intake, MTHFR Polymorphisms, and Risk of Esophageal, Gastric, and Pancreatic Cancer: A Meta-analysis. Gastroenterology 131: 1271-1283.
47. Langevin S, Lin D, Matsuo K, Gao C, Takezaki T, et al. (2009) Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett 184: 73-80.
48. Zintzaras E, (2006) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 51: 618-624.
49. Zacho J, Yazdanyar S, Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG, (2011) Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677C>T polymorphism and risk of cancer: Cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls. Int J Cancer 128: 644-652.